These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2742829)

  • 21. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Viale M; Cafaggi S; Parodi B; Esposito M
    Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cells.
    Chao CC
    Eur J Pharmacol; 1994 Aug; 268(3):347-55. PubMed ID: 7805758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host cell reactivation by human cells of DNA expression vectors damaged by ultraviolet radiation or by acid-heat treatment.
    Protić-Sabljić M; Kraemer KH
    Carcinogenesis; 1986 Oct; 7(10):1765-70. PubMed ID: 3463438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
    Chao CC
    Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II).
    Swinnen LJ; Fisher SG; Erickson LC
    Carcinogenesis; 1989 Aug; 10(8):1465-70. PubMed ID: 2752520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.
    Heiger-Bernays WJ; Essigmann JM; Lippard SJ
    Biochemistry; 1990 Sep; 29(36):8461-6. PubMed ID: 2174701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in mouse leukemia cell lines.
    Tashiro T; Sato Y
    Jpn J Cancer Res; 1992 Feb; 83(2):219-25. PubMed ID: 1556003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repair of sulfur mustard-induced DNA damage in mammalian cells measured by a host cell reactivation assay.
    Matijasevic Z; Precopio ML; Snyder JE; Ludlum DB
    Carcinogenesis; 2001 Apr; 22(4):661-4. PubMed ID: 11285203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells.
    Farnworth P; Hillcoat B; Roos I
    Cancer Chemother Pharmacol; 1990; 25(6):411-7. PubMed ID: 2311168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of reporter gene expression in mammalian cells. Effects of distinct carcinogen lesions in DNA.
    Sorscher DH; Cordeiro-Stone M
    Carcinogenesis; 1994 May; 15(5):1093-6. PubMed ID: 8200075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells.
    Vilpo JA; Vilpo LM; Szymkowski DE; O'Donovan A; Wood RD
    Mol Cell Biol; 1995 Jan; 15(1):290-7. PubMed ID: 7799936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.
    Fram RJ; Woda BA; Wilson JM; Robichaud N
    Cancer Res; 1990 Jan; 50(1):72-7. PubMed ID: 2293559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy.
    Zeng-Rong N; Paterson J; Alpert L; Tsao MS; Viallet J; Alaoui-Jamali MA
    Cancer Res; 1995 Nov; 55(21):4760-4. PubMed ID: 7585500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.
    Poirier MC; Lippard SJ; Zwelling LA; Ushay HM; Kerrigan D; Thill CC; Santella RM; Grunberger D; Yuspa SH
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6443-7. PubMed ID: 6959129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host cell reactivation of CAT-expression vectors as a method to assay for cloned DNA-repair genes.
    Henderson EE; Valerie K; Green AP; de Riel JK
    Mutat Res; 1989; 220(2-3):151-60. PubMed ID: 2927423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
    Murray D; Jenkins WT; Meyn RE
    Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
    Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
    Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of cis-diamminedichloroplatinum(II) with sensitive and resistant L1210 cell lines. Drug binding to nuclei and DNA.
    Foka M; Belehradek J; Paoletti J
    Biochem Pharmacol; 1988 Sep; 37(18):3467-72. PubMed ID: 3421997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.